empagliflozin semaglutide Ozempic outperforms another diabetes drug for reducing stroke risk Separate and combined effects of

This hormone is responsible for appetite suppression and a feeling of fullness or satiety

Clinical trials such as the STEP program (semaglutide) and SURMOUNT trials (tirzepatide) demonstrate that patients typically experience reduced caloric intake, with many reporting decreased interest in food and smaller portion sizes

Consistency in taking the medication is key to achieving the desired effects

We partner with medical professionals who use HIIPA-compliant platforms to deliver services

Plus, the PIs for these two medications give more focus to the top 56 side effects experienced by participants in clinical trials, which include nausea , vomiting, diarrhea, abdominal pain, and constipation